This finding will make it possible to personalise treatments and in some cases find alternatives to operations that involve significant aesthetic and physical damage that reduces the patient’s quality of life.

The molecule found makes possible an early diagnosis of whether a patient is at greater risk of suffering health complications as a result of this disease. The study has been led by a research group from the URV and the IISPV.